1 year return (CAGR)
586.37%
ImmunoGen Inc Exchange (NASDAQ, USD)
IMGN
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
55.79%
5 year return (CAGR)
43.46%
10 year return (CAGR)
8.00%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
8.72B
Price/Sales
30.33
Ent value
8.38B
Price/Book
15.53
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
86.75
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 31.24 |
| Daily high | 31.25 |
| Daily low | 31.22 |
| Daily Volume | 47.4M |
| 1y analyst estimate | 25.50 |
| Beta | 1.17 |
| EPS (TTM) | -0.25 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IMGN | S&P500 | |
| Current price drop from All-time high | -28.72% | -0.07% |
| Highest price drop | -96.48% | -56.47% |
| Date of highest drop | 31 Dec 1997 | 9 Mar 2009 |
| Avg drop from high | -76.29% | -10.68% |
| Avg time to new high | 162 days | 12 days |
| Max time to new high | 5849 days | 1805 days |
News
No items found